Get started
Direxion Daily S&P Biotech Bear 3X SharesDirexion Daily S&P Biotech Bear 3X SharesDirexion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

No trades
See on Supercharts
Overview Analysis Holdings News
Ideas
Discussions Technicals Seasonals Options

LABD trade ideas

Direxion Daily S&P Biotech Bear 3X Shares (LABD)On daily chart, LABD is trading in an uptrend, and by Friday’s session, LABD has broken major resistance that lies on 29.19$, and the confirmation of that breakout, will trigger LABD witness further rises near to 31.72 – 34.20 – 41.40 – 42.71 om short term basis. Stop loss will lies below 25.66$(last bottom). And we noticed that, the indicators heading towards positive side, which confirm the positive scenario mention above.
AMEX:LABDLong
by Gehad_Abouelela
1
LABD 3X BEAR BIOTECH LONG DAYTRADEAs shown on the 15-minute chart, LABD is bouncing between stardard deviations of the VWAP in a 6% price range fluctuation day to day. At the upper end it is reversing at the POC of the volume profile confluent with one standard deviation above VWAP while at the bottom it is bouncing from the bottom of the lower high volume area of the profile and two standard deviations below VWAP. I see this as an opportunity for a 6% upside long day trade especially if the general market is uptrending after the weekend. Alternatively, a 5 DTE call option with a strike of $ 15.50 or $16.00 looking for a 30-40% return on the premium over the upcoming week. ( The zero lag MACD confirms the buy signal.)
AMEX:LABDLong
by AwesomeAvani
LABD false breakdownXBI has been super weak lately, and in our earlier decline lead the way down. On the whole I think its a garbage sector RN with the amount of uncertainty in the market and the fed raising rates. The chop it's experienced in the past few months is textbook bearmarket. No one wants it, but everyone's too scared to sell too. Regardless, technical setup is same as last time. Could run, use the second close below the 10day MA IMO, if it begins to go parabolic, like last time, start trailing with yesterday's low as the hard stop.
AMEX:LABDLong
by JamesMBee
LABD break outI have been tackling LABD/LABU day in and day out. I have somehow made some profit week by week. I am trying to figure out which was the better trade as I think it has come to the tipping point. I believe LABD is the winner. I see bearish sentiment in the short term market and I see an inverse head and shoulders or a cup and handle formation. On LABU I confirmed it because whichever way I look at it it is the opposite, head and shoudler pattern, inverse cup and handle.
AMEX:LABDLong
by umaidsiddiqui786
Is LABD looking to break out of this ascending triangle?As far as popular reversal patterns go, ascending triangles are no bottom of the barrel. Although I still am a new trader, I have been committed to the market for just over 1 year. With that said I have been watching LABD/LABU in proximity of market trends. When the overall market is bullish I trade LABU with success. When Market is bearish I trade LABD with success. My number #1 rule is follow the trend. That is why I am bullish on LABD. With the market making irrational highs despite COVID fears of a new variant, I have noted that LABD make this ascending triangle formation. So far it has held true. This could just be paranoid shizophrenia (I have an MD by the way), but my inner voice has been telling me to watch biotech for the market fall. My theory is that if and when the market falls LABD is going to get pumped like there is no tomorrow, similar to the VIX. But the good part is it is not as volatile as fear is. I can trade its inverse and watch the volume in both directions. So far it seems even, so i don't think any one knows what is coming next, except for maybe the FED. Unless LABU turns around I think LABD can go up to 40, if in fact there is a bubble burst on the horizon.
AMEX:LABDLong
by umaidsiddiqui786
1
$LABD PT 40 and higherThe investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
AMEX:LABDLong
by BADQOMOCAWGOWLD
2